Restricted accessResearch articleFirst published online 2014-05
An Epigenetic Biomarker Panel for Glioblastoma Multiforme Personalized Medicine through DNA Methylation Analysis of Human Embryonic Stem Cell-like Signature
Alterations of DNA methylation occur during the course of both stem cell development and tumorigenesis. We present a novel strategy that can be used to stratify glioblastoma multiforme (GBM) patients through the epigenetic states of genes associated with human embryonic stem cell (hESC) identity in order to 1) assess linkages between the methylation signatures of these stem cell genes and survival of GBM patients, and 2) delineate putative mechanisms leading to poor prognosis in some patient subgroups. A DNA methylation signature was established for stratifying GBM patients into several hESC methylator subgroups. The hESC methylator-negative phenotype has demonstrated poor survival and upregulation of glioma stem cell (GSC) markers, and is enriched in one of the previously defined transcriptomic phenotypes—the mesenchymal phenotype. We further identified a refined signature of 36 genes as the gene panel, including SOX2, POU3F2, FGFR2, GAP43, NTRK2, NTRK3, and NKX2-2, which are highly enriched in the nervous system. Both signatures outperformed the O6-methylguanine-DNA methyltransferase (MGMT) methylation test in predicting patient's outcome. These findings were also validated through an independent dataset of patients. Furthermore, through statistical analyses, both signatures were examined significantly. Hypomethylation of hESC-associated genes predicted poorer clinical outcome in GBM, supporting the idea that epigenetic activation of stem cell genes contributes to GBM aggression. The gene panel presented herein may be developed into clinical assays for patient stratification and future personalized medicine interventions.
Get full access to this article
View all access options for this article.
References
1.
AignerL, ArberS, KapfhammerJP, et al. (1995). Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell, 83, 269–278.
2.
AssouS, Le CarrourT, TondeurS, et al. (2007). A meta-analysis of human embryonic stem cells Transcriptome integrated into a web-based expression atlas. Stem Cells, 25, 961–973.
3.
AvilionAA, NicolisSK, PevnyLH, PerezL, VivianN, and Lovell-BadgeR. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Devel, 17, 126–140.
4.
BaoS, WuQ, LiZ, et al. (2008). Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res, 68, 6043–6048.
5.
BaoS, WuQ, MclendonRE, et al. (2006a). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756–760.
6.
BaoS, WuQ, SathornsumeteeS, et al. (2006b). Stem cell–like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res, 66, 7843–7848.
7.
BaylinSB, and OhmJE. (2006). Epigenetic gene silencing in cancer. A mechanism for early oncogenic pathway addiction?. Nat Rev Cancer, 6, 107–116.
8.
Ben-PorathI, ThomsonMW, CareyVJ, et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 40, 499–507.
9.
BenowitzLI, and RouttenbergA. (1997). GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci, 20, 84–91.
10.
BoyerLA, LeeTI, ColeMF, et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122, 947–956.
11.
BriscoeJ, SusselL, SerupP, et al. (1999). Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature, 398, 622–627.
12.
CalabreseC, PoppletonH, KocakM, et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell, 11, 69–82.
13.
ChiangC, LitingtungY, LeeE, et al. (1996). Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature, 383, 407–413.
14.
DentEW, and MeiriKF. (1998). Distribution of phosphorylated GAP-43 (neuromodulin) in growth cones directly reflects growth cone behavior. J Neurobiol, 35, 287–299.
15.
EricsonJ, MuhrJ, PlaczekM, LintsT, JesselTM, and EdlundT. (1995). Sonic hedgehog induces the differentiation of ventral forebrain neurons: A common signal for ventral patterning within the neural tube. Cell, 81, 747–756.
16.
EverL, ZhaoR, EswarakumarVP, and GaianoN. (2008). Fibroblast growth factor receptor 2 plays an essential role in telencephalic progenitors. Develop Neurosci, 30, 306–318.
17.
FeinbergAP, OhlssonR, and HenikoffS. (2006). The epigenetic progenitor origin of human cancer. Nat Rev Genet, 7, 21–33.
18.
FeinbergAP, and TyckoB (2004). The history of cancer epigenetics. Nat Rev Cancer, 4, 143–153.
19.
FeinbergAP, and VogelsteinB. (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 301, 89–92.
20.
FernandezPC, FrankSR, WangL, et al. (2003). Genomic targets of the human c-Myc protein. Genes Devel, 17, 1115–1129.
21.
FigueroaME, SkrabanekL, LiY, et al. (2009). MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood, 114, 3448–3458.
22.
FuccilloM, JoynerAL, and FishellG. (2006). Morphogen to mitogen: The multiple roles of hedgehog signalling in vertebrate neural development. Nat Rev Neurosci, 7, 772–783.
23.
GalliR, BindaE, OrfanelliU, et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 64, 7011–7021.
24.
GrahamV, KhudyakovJ, EllisP, and PevnyL. (2003). SOX2 functions to maintain neural progenitor identity. Neuron, 39, 749–765.
25.
GravendeelLaM, KouwenhovenMCM, GevaertO, et al. (2009). Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res, 69, 9065–9072.
26.
GutinG, FernandesM, PalazzoloL, et al. (2006). FGF signalling generates ventral telencephalic cells independently of SHH. Development, 133, 2937–2946.
27.
Hagino-YamagishiK, SaijohY, IkedaM, IchikawaM, Minamikawa-TachinoR, and HamadaH. (1997). Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. Brain Res, 752, 261–268.
28.
HeX, TreacyMN, SimmonsDM, IngrahamHA, SwansonLW, and RosenfeldMG. (1989). Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature, 340, 35–42.
29.
HegiME, DiserensA-C, GorliaT, et al. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. New Eng J Med, 352, 997–1003.
30.
HemmatiHD, NakanoI, LazareffJA, et al. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci, 100, 15178–15183.
31.
HollidayR, and PughJ. (1975). DNA modification mechanisms and gene activity during development. Science, 187, 226–232.
32.
IrizarryRA, Ladd-AcostaC, WenB, et al. (2009). The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet, 41, 178–186.
33.
KleinR, ParadaLF, CoulierF, and BarbacidM. (1989). trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J, 8, 3701–3709.
34.
KleinR, ConwayD, ParadaLF, and BarbacidM. (1990a). The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell, 61, 647–656.
35.
KleinR, Martin-ZancaD, BarbacidM, and ParadaLF. (1990b). Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. Development, 109, 845–850.
36.
KleinR, Silos-SantiagoI, SmeyneRJ, et al. (1994). Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature, 368, 249–251.
37.
KleinR, SmeyneRJ, WurstW, et al. (1993). Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell, 75, 113–122.
38.
LamballeF, KleinR, and BarbacidM. (1991). trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell, 66, 967–979.
39.
LeeJ, KotliarovaS, KotliarovY, et al. (2006a). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9, 391–403.
40.
LeeTI, JennerRG, BoyerLA, et al. (2006b). Control of developmental regulators by polycomb in human embryonic stem cells. Cell, 125, 301–313.
41.
Levi-MontalciniR. (1987). The nerve growth factor: Thirty-five years later. EMBO J, 6, 1145–1154.
42.
LiZ, BaoS, WuQ, et al. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15, 501–513.
43.
LiZ, Van CalcarS, QuC, CaveneeWK, ZhangMQ, and RenB. (2003). A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci, 100, 8164–8169.
44.
MaricD, Fiorio PlaA, ChangYH, and BarkerJL. (2007). Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors. J Neurosci, 27, 1836–1852.
45.
MartiE, BumcrotDA, TakadaR, and McMahonAP. (1995). Requirement of 19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. Nature, 375, 322–325.
46.
MasonI. (2007). Initiation to end point: The multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci, 8, 583–596.
MiyagiS, MasuiS, NiwaH, SaitoT, ShimazakiT, OkanoH, et al. (2008). Consequence of the loss of Sox2 in the developing brain of the mouse. FEBS Lett, 582, 2811–2815.
49.
MuratA, MigliavaccaE, GorliaT, et al. (2008). Stem cell–related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol, 26, 3015–3024.
50.
NakaiS, KawanoH, YudateT, et al. (1995). The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Devel, 9, 3109–3121.
51.
NoushmehrH, WeisenbergerDJ, DiefesK, et al. (2010). Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell, 17, 510–522.
52.
OrdwayJM, BudimanMA, KorshunovaY, et al. (2007). Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS ONE, 2, e1314.
53.
PaekH, GutinG, and HébertJM. (2009). FGF signaling is strictly required to maintain early telencephalic precursor cell survival. Development, 136, 2457–2465.
54.
ParsonsDW, JonesS, ZhangX, et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807–1812.
55.
PevnyL, and RaoMS. (2003). The stem-cell menagerie. Trends Neurosci, 26, 351–359.
56.
PhillipsHS, KharbandaS, ChenR, et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9, 157–173.
57.
RauchTA, ZhongX, WuX, et al. (2008). High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci, 105, 252–257.
58.
RiggsAD. (1975). X inactivation, differentiation, and DNA methylation. Cytogen Genome Res, 14, 9–25.
59.
RoelinkH, PorterJA, ChiangC, et al. (1995). Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell, 81, 445–455.
60.
SchonemannMD, RyanAK, McEvillyRJ, et al. (1995). Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Devel, 9, 3122–3135.
61.
SinghSK, HawkinsC, ClarkeID, et al. (2004). Identification of human brain tumour initiating cells. Nature, 432, 396–401.
62.
SpergerJM, ChenX, DraperJS, et al. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci, 100, 13350–13355.
63.
StrittmatterSM, ValenzuelaD, KennedyTE, NeerEJ, and FishmanMC. (1990). G0 is a major growth cone protein subject to regulation by GAP-43. Nature, 344, 836–841.
64.
SugitaniY, NakaiS, MinowaO, et al. (2002). Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. Genes Devel, 16, 1760–1765.
65.
TakahashiK, TanabeK, OhnukiM, et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
66.
TakahashiK, and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
67.
The Cancer Genome Atlas Research Network. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061–1068.
68.
ToyotaM, AhujaN, Ohe-ToyotaM, HermanJG, BaylinSB, and IssaJ-PJ. (1999). CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci, 96, 8681–8686.
69.
UchikawaM, IshidaY, TakemotoT, KamachiY, and KondohH. (2003). Functional analysis of chicken Sox2 enhancers highlights an array of diverse regulatory elements that are conserved in mammals. Devel Cell, 4, 509–519.
70.
UmemoriH, LinhoffMW, OrnitzDM, and SanesJR. (2004). FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell, 118, 257–270.
71.
VerhaakRGW, HoadleyKA, PurdomE, et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98–110.
72.
VierbuchenT, OstermeierA, PangZP, KokubuY, SüdhofTC, and WernigM. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463, 1035–1041.
73.
VokesSA, JiH, MccuineS, et al. (2007). Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development, 134, 1977–1989.
74.
XuQ, GuoL, MooreH, WaclawRR, CampbellK, and AndersonSA. (2010). Sonic Hedgehog signaling confers ventral telencephalic progenitors with distinct cortical interneuron fates. Neuron, 65, 328–340.
75.
XuQ, WondersCP, and AndersonSA. (2005). Sonic hedgehog maintains the identity of cortical interneuron progenitors in the ventral telencephalon. Development, 132, 4987–4998.
76.
ZapponeMV, GalliR, CatenaR, et al. (2000). Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development, 127, 2367–2382.
77.
ZweigMH, and CampbellG. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem, 39, 561–577.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
